AMN
AMN Healthcare Services, Inc.
Medical - Care Facilities
Market Cap$869M
5Y Perf.-34.7%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
AMN vs TBI vs MAN vs CCRN vs KELYA
Revenue, margins, valuation, and 5-year total return — side by side.
TBI
TrueBlue, Inc.
Staffing & Employment Services
Market Cap$182M
5Y Perf.-63.7%
MAN
ManpowerGroup Inc.
Staffing & Employment Services
Market Cap$1.41B
5Y Perf.-56.8%
CCRN
Cross Country Healthcare, Inc.
Medical - Care Facilities
Market Cap$423M
5Y Perf.+117.1%
KELYA
Kelly Services, Inc.
Staffing & Employment Services
Market Cap$349M
5Y Perf.-34.2%
AMN vs TBI vs MAN vs CCRN vs KELYA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AMN | TBI | MAN | CCRN | KELYA |
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Staffing & Employment Services | Staffing & Employment Services | Medical - Care Facilities | Staffing & Employment Services |
| Market Cap | $869M | $182M | $1.41B | $423M | $349M |
| Revenue (TTM) | $3.42B | $1.25B | $17.96B | $761M | $3.09B |
| Net Income (TTM) | $-32M | $-53M | $-13M | $-99M | $-266M |
| Gross Margin | 25.5% | 28.4% | 16.7% | 18.2% | 26.3% |
| Operating Margin | 0.3% | -2.6% | 0.8% | -0.9% | -2.8% |
| Forward P/E | 14.2x | — | 8.1x | 156.2x | 11.2x |
| Total Debt | $803M | $171M | $2.39B | $2M | $159M |
| Cash & Equiv. | $34M | $25M | $871M | $109M | $33M |
AMN vs TBI vs MAN vs CCRN vs KELYA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AMN
TBI
MAN
CCRN
KELYA
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMN Healthcare Serv… (AMN) | 100 | 65.3 | -34.7% |
| TrueBlue, Inc. (TBI) | 100 | 36.3 | -63.7% |
| ManpowerGroup Inc. (MAN) | 100 | 43.2 | -56.8% |
| Cross Country Healt… (CCRN) | 100 | 217.1 | +117.1% |
| Kelly Services, Inc. (KELYA) | 100 | 65.8 | -34.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMN vs TBI vs MAN vs CCRN vs KELYA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MAN leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. TrueBlue, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. CCRN also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AMN
AMN Healthcare Services, Inc.
The Value Angle
AMN lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: healthcare exposure
TBI
TrueBlue, Inc.
The Growth Play
TBI is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 3.1%, EPS growth 61.4%, 3Y rev CAGR -10.5%
- 3.1% revenue growth vs CCRN's -21.6%
- +51.0% vs MAN's -17.0%
Best for: growth exposure
MAN
ManpowerGroup Inc.
The Value Play
MAN carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (8.1x vs 156.2x)
- -0.1% margin vs CCRN's -13.0%
- 4.7% yield, vs KELYA's 3.2%, (3 stocks pay no dividend)
- -0.1% ROA vs CCRN's -19.8%, ROIC 5.6% vs -0.9%
Best for: value and quality
CCRN
Cross Country Healthcare, Inc.
The Long-Run Compounder
CCRN ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- -10.5% 10Y total return vs MAN's -30.8%
- Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
- Beta 0.78, current ratio 3.78x
- Beta 0.78 vs TBI's 1.13, lower leverage
Best for: long-term compounding and sleep-well-at-night
KELYA
Kelly Services, Inc.
The Income Pick
KELYA is the clearest fit if your priority is income & stability.
- Dividend streak 5 yrs, beta 1.01, yield 3.2%
Best for: income & stability
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | TBI | 3.1% revenue growth vs CCRN's -21.6% |
| Value | MAN | Lower P/E (8.1x vs 156.2x) |
| Quality / Margins | MAN | -0.1% margin vs CCRN's -13.0% |
| Stability / Safety | CCRN | Beta 0.78 vs TBI's 1.13, lower leverage |
| Dividends | MAN | 4.7% yield, vs KELYA's 3.2%, (3 stocks pay no dividend) |
| Momentum (1Y) | TBI | +51.0% vs MAN's -17.0% |
| Efficiency (ROA) | MAN | -0.1% ROA vs CCRN's -19.8%, ROIC 5.6% vs -0.9% |
AMN vs TBI vs MAN vs CCRN vs KELYA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2024
FY 2025
FY 2025
AMN vs TBI vs MAN vs CCRN vs KELYA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMANLAGGINGKELYA
Who Leads Where
MAN leads in 2 of 6 categories
AMN leads 1 • CCRN leads 1 • TBI leads 0 • KELYA leads 0 • 2 tied
Explore the data ↓KELYAKelly Services, Inc.
0leads
TBITrueBlue, Inc.
0leads
CCRNCross Country Healthc…
1leads
AMNAMN Healthcare Servic…
1leads
MANManpowerGroup Inc.
2leads
6 Total Categories
CATEGORYLEADERvs AMNvs CCRNMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
AMN3/6
Valuation MetricsMultiples, price ratios, and targets
MAN3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MAN5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CCRN3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
AMN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 23.6x CCRN's $761M. MAN is the more profitable business, keeping -0.1% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AMNAMN Healthcare Se… | TBITrueBlue, Inc. | MANManpowerGroup Inc. | CCRNCross Country Hea… | KELYAKelly Services, I… |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.4B | $1.2B | $18.0B | $761M | $3.1B |
| EBITDAEarnings before interest/tax | $127M | -$10M | $236M | $9M | -$54M |
| Net IncomeAfter-tax profit | -$32M | -$53M | -$13M | -$99M | -$266M |
| Free Cash FlowCash after capex | $714M | -$60M | -$161M | $41M | $66M |
| Gross MarginGross profit ÷ Revenue | +25.5% | +28.4% | +16.7% | +18.2% | +26.3% |
| Operating MarginEBIT ÷ Revenue | +0.3% | -2.6% | +0.8% | -0.9% | -2.8% |
| Net MarginNet income ÷ Revenue | -0.9% | -4.3% | -0.1% | -13.0% | -8.6% |
| FCF MarginFCF ÷ Revenue | +20.9% | -4.8% | -0.9% | +5.4% | +2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +99.9% | -100.0% | +7.1% | -100.0% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.8% | -37.5% | +36.2% | -6.0% | -2.1% |
AMN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
MAN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | AMNAMN Healthcare Se… | TBITrueBlue, Inc. | MANManpowerGroup Inc. | CCRNCross Country Hea… | KELYAKelly Services, I… |
|---|---|---|---|---|---|
| Market CapShares × price | $869M | $182M | $1.4B | $423M | $349M |
| Enterprise ValueMkt cap + debt − cash | $1.6B | $329M | $2.9B | $317M | $475M |
| Trailing P/EPrice ÷ TTM EPS | -9.06x | -3.73x | -104.90x | -4.47x | -1.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.24x | — | 8.12x | 156.16x | 11.15x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.63x | 160.03x | 9.02x | 23.75x | — |
| Price / SalesMarket cap ÷ Revenue | 0.32x | 0.11x | 0.08x | 0.40x | 0.08x |
| Price / BookPrice ÷ Book value/share | 1.35x | 0.65x | 0.69x | 1.31x | 0.35x |
| Price / FCFMarket cap ÷ FCF | 3.72x | — | — | 10.55x | 3.06x |
MAN leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
MAN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MAN delivers a -0.6% return on equity — every $100 of shareholder capital generates $-1 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.25x. On the Piotroski fundamental quality scale (0–9), CCRN scores 6/9 vs MAN's 1/9, reflecting solid financial health.
| Metric | AMNAMN Healthcare Se… | TBITrueBlue, Inc. | MANManpowerGroup Inc. | CCRNCross Country Hea… | KELYAKelly Services, I… |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.0% | -18.7% | -0.6% | -27.1% | -24.6% |
| ROA (TTM)Return on assets | -1.4% | -8.1% | -0.1% | -19.8% | -11.3% |
| ROICReturn on invested capital | +1.6% | -5.2% | +5.6% | -0.9% | -4.0% |
| ROCEReturn on capital employed | +2.0% | -5.3% | +6.2% | -0.8% | -4.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 1 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.25x | 0.62x | 1.16x | 0.01x | 0.16x |
| Net DebtTotal debt minus cash | $769M | $146M | $1.5B | -$106M | $126M |
| Cash & Equiv.Liquid assets | $34M | $25M | $871M | $109M | $33M |
| Total DebtShort + long-term debt | $803M | $171M | $2.4B | $2M | $159M |
| Interest CoverageEBIT ÷ Interest expense | -1.70x | -46.19x | 1.98x | -1.39x | -12.07x |
MAN leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CCRN leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCRN five years ago would be worth $7,746 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, TBI leads with a +51.0% total return vs MAN's -17.0%. The 3-year compound annual growth rate (CAGR) favors KELYA at -13.0% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | AMNAMN Healthcare Se… | TBITrueBlue, Inc. | MANManpowerGroup Inc. | CCRNCross Country Hea… | KELYAKelly Services, I… |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +48.7% | +36.6% | +1.2% | +62.4% | +13.1% |
| 1-Year ReturnPast 12 months | +14.6% | +51.0% | -17.0% | -5.4% | -12.2% |
| 3-Year ReturnCumulative with dividends | -75.1% | -60.2% | -46.4% | -44.3% | -34.2% |
| 5-Year ReturnCumulative with dividends | -75.1% | -78.7% | -64.9% | -22.5% | -58.3% |
| 10-Year ReturnCumulative with dividends | -41.5% | -68.4% | -30.8% | -10.5% | -33.0% |
| CAGR (3Y)Annualised 3-year return | -37.1% | -26.4% | -18.8% | -17.7% | -13.0% |
CCRN leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — AMN and CCRN each lead in 1 of 2 comparable metrics.
Risk & Volatility
CCRN is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs MAN's 64.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AMNAMN Healthcare Se… | TBITrueBlue, Inc. | MANManpowerGroup Inc. | CCRNCross Country Hea… | KELYAKelly Services, I… |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.98x | 0.89x | 0.68x | 0.96x |
| 52-Week HighHighest price in past year | $23.74 | $7.78 | $47.34 | $14.99 | $14.94 |
| 52-Week LowLowest price in past year | $14.87 | $3.18 | $25.15 | $7.43 | $7.98 |
| % of 52W HighCurrent price vs 52-week peak | +94.7% | +77.2% | +64.3% | +87.3% | +64.9% |
| RSI (14)Momentum oscillator 0–100 | 57.2 | 83.2 | 47.1 | 53.1 | 63.7 |
| Avg Volume (50D)Average daily shares traded | 849K | 386K | 1.1M | 552K | 361K |
Evenly matched — AMN and CCRN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — MAN and KELYA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AMN as "Buy", TBI as "Buy", MAN as "Hold", CCRN as "Hold", KELYA as "Buy". Consensus price targets imply 54.6% upside for KELYA (target: $15) vs -18.9% for CCRN (target: $11). For income investors, MAN offers the higher dividend yield at 4.71% vs KELYA's 3.23%.
| Metric | AMNAMN Healthcare Se… | TBITrueBlue, Inc. | MANManpowerGroup Inc. | CCRNCross Country Hea… | KELYAKelly Services, I… |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $23.38 | $5.50 | $37.86 | $10.61 | $15.00 |
| # AnalystsCovering analysts | 17 | 10 | 29 | 14 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | — | +4.7% | — | +3.2% |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 1 | 5 |
| Dividend / ShareAnnual DPS | — | — | $1.43 | — | $0.31 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +0.6% | +2.7% | +1.6% | +3.5% |
Evenly matched — MAN and KELYA each lead in 1 of 2 comparable metrics.
Key Takeaway
MAN leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). AMN leads in 1 (Income & Cash Flow). 2 tied.
Best OverallManpowerGroup Inc. (MAN)Leads 2 of 6 categories
Loading custom metrics...
AMN vs TBI vs MAN vs CCRN vs KELYA: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is AMN or TBI or MAN or CCRN or KELYA a better buy right now?
For growth investors, TrueBlue, Inc.
(TBI) is the stronger pick with 3. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AMN or TBI or MAN or CCRN or KELYA?
Over the past 5 years, Cross Country Healthcare, Inc.
(CCRN) delivered a total return of -22. 5%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: CCRN returned -9. 9% versus TBI's -70. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AMN or TBI or MAN or CCRN or KELYA?
By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.
(CCRN) is the lower-risk stock at 0. 68β versus AMN Healthcare Services, Inc. 's 1. 12β — meaning AMN is approximately 65% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 125% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AMN or TBI or MAN or CCRN or KELYA?
By revenue growth (latest reported year), TrueBlue, Inc.
(TBI) is pulling ahead at 3. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, MAN leads at -3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AMN or TBI or MAN or CCRN or KELYA?
ManpowerGroup Inc.
(MAN) is the more profitable company, earning -0. 1% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps -0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAN leads at 1. 3% versus -1. 7% for TBI. At the gross margin level — before operating expenses — AMN leads at 22. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is AMN or TBI or MAN or CCRN or KELYA more undervalued right now?
On forward earnings alone, ManpowerGroup Inc.
(MAN) trades at 8. 1x forward P/E versus 156. 2x for Cross Country Healthcare, Inc. — 148. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 54. 6% to $15. 00.
07Which pays a better dividend — AMN or TBI or MAN or CCRN or KELYA?
In this comparison, MAN (4.
7% yield), KELYA (3. 2% yield) pay a dividend. AMN, TBI, CCRN do not pay a meaningful dividend and should not be held primarily for income.
08Is AMN or TBI or MAN or CCRN or KELYA better for a retirement portfolio?
For long-horizon retirement investors, ManpowerGroup Inc.
(MAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 4. 7% yield). Both have compounded well over 10 years (MAN: -31. 5%, AMN: -24. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AMN and TBI and MAN and CCRN and KELYA?
These companies operate in different sectors (AMN (Healthcare) and TBI (Industrials) and MAN (Industrials) and CCRN (Healthcare) and KELYA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AMN is a small-cap quality compounder stock; TBI is a small-cap quality compounder stock; MAN is a small-cap income-oriented stock; CCRN is a small-cap quality compounder stock; KELYA is a small-cap income-oriented stock. MAN, KELYA pay a dividend while AMN, TBI, CCRN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(AMN: 99.9% · TBI: -100.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.